A Pipeline Win as BridgeBio Learns to Balance Theory with Practice

Neil Kumar, co-founder and CEO of BridgeBio, discusses the approval of its ATTR-CM therapy Attruby, the company’s late-stage pipeline, and what he’s learned about its business model in the process.